Lung cancer: therapeutic options for stage IV and recurrent NSCLC.

A. R. Calvo; C. P. Belani

doi:10.1007/978-1-4615-1589-0_8

Lung cancer: therapeutic options for stage IV and recurrent NSCLC.

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	189-227
Number of pages	39
Journal	Cancer treatment and research
Volume	105
DOIs	https://doi.org/10.1007/978-1-4615-1589-0_8
State	Published - 2001

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-1-4615-1589-0_8

Cite this

@article{654958bb95a5442d8588e98b4708cc7a,

title = "Lung cancer: therapeutic options for stage IV and recurrent NSCLC.",

author = "Calvo, {A. R.} and Belani, {C. P.}",

year = "2001",

doi = "10.1007/978-1-4615-1589-0_8",

language = "English (US)",

volume = "105",

pages = "189--227",

journal = "Cancer treatment and research",

issn = "0927-3042",

publisher = "Springer Netherlands",

}

TY - JOUR

T1 - Lung cancer

T2 - therapeutic options for stage IV and recurrent NSCLC.

AU - Calvo, A. R.

AU - Belani, C. P.

PY - 2001

Y1 - 2001

UR - http://www.scopus.com/inward/record.url?scp=0035221315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035221315&partnerID=8YFLogxK

U2 - 10.1007/978-1-4615-1589-0_8

DO - 10.1007/978-1-4615-1589-0_8

M3 - Review article

C2 - 11224988

AN - SCOPUS:0035221315

SN - 0927-3042

VL - 105

SP - 189

EP - 227

JO - Cancer treatment and research

JF - Cancer treatment and research

ER -

Lung cancer: therapeutic options for stage IV and recurrent NSCLC.

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this